TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Oregon Center Launching $1 Billion Program To Identify Lethal Cancers Before They Kill May 9, 2014